{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-037851","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.364607+00:00","generated_at":"2026-06-04T09:28:48.631773+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Masimo board authorizes evaluation of consumer business separation; retains healthcare","bullets":["Board authorized management to evaluate separation of consumer business (audio + health products: Stork, Freedom).","Masimo will retain professional healthcare and telehealth products; expects improved profitability.","Joe Kiani to remain Chairman and CEO of Masimo and become Chairman of the new company.","Separation timing subject to due diligence, definitive agreements, SEC clearance, and regulatory approvals.","Masimo reaffirms Q1 and fiscal 2024 financial guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-037851","json":"https://secwatch.observer/filing/0001104659-24-037851.json","markdown":"https://secwatch.observer/filing/0001104659-24-037851.md","text":"https://secwatch.observer/filing/0001104659-24-037851.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000110465924037851/0001104659-24-037851-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000110465924037851/tm249575d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:28:48.631773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}